On March 25, 2022, Carl Sandler provided notice of his resignation as a member of the Board of Directors of Enochian Biosciences Inc. to focus on his other business ventures, with such resignation being effective March 25, 2022.
Market Closed -
Other stock markets
|
5-day change | 1st Jan Change | ||
1.44 USD | -0.69% |
|
-0.69% | -54.57% |
06-14 | Renovaro Says Investors Commit $10 Million Additional Equity | MT |
05-24 | Renovaro, Amsterdam UMC Cancer Center Plan to Form Joint Venture for Cancer Immunotherapy | MT |
1st Jan change | Capi. | |
---|---|---|
-54.57% | 214M | |
+15.85% | 121B | |
+18.91% | 112B | |
+4.43% | 22.57B | |
-18.63% | 20.82B | |
-13.76% | 16.3B | |
-16.61% | 16.19B | |
-43.53% | 16.17B | |
+1.75% | 13.17B | |
+28.07% | 11.11B |
- Stock Market
- Equities
- RENB Stock
- News Renovaro Inc.
- Enochian Biosciences, Inc. Announces Resignation of Carl Sandler as Member of the Board of Directors